Preoperative renal function affects outcomes of surgery for aortic arch aneurysm in the elderly.


Journal

General thoracic and cardiovascular surgery
ISSN: 1863-6713
Titre abrégé: Gen Thorac Cardiovasc Surg
Pays: Japan
ID NLM: 101303952

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 11 09 2020
accepted: 07 11 2020
pubmed: 26 11 2020
medline: 17 6 2021
entrez: 25 11 2020
Statut: ppublish

Résumé

This study aimed to determine the optimal surgical procedure for arch aneurysm in the elderly based on preoperative comorbidities, especially focusing on renal function. The medical records of 374 patients who experienced arch surgery between 2008 and 2019 were reviewed. Among the 374 patients, 92 who underwent total arch replacement (TAR) were assigned to the TAR group and the remaining 152 who underwent debranching thoracic endovascular aortic repair (DTEVAR) were assigned to the DTEVAR group. Chronic kidney disease (CKD) was an independent risk factor of mortality (hazard ratio, 2.85; p = 0.029) in the TAR group but not in the DTEVAR. In the Grade I/II category CKD (estimated glomerular filtration rate (eGFR) > 60 mL/min), freedom from all-cause mortality was significantly higher in the TAR group than in the DTEVAR group (p = 0.0155, log-rank). Freedom from all-cause mortality was comparable between the two groups in the Grade IIIa CKD (eGFR, 45-60) (p = 0.584, log-lank), Grade IIIb (eGFR, 30-45) (p = 0.822), and Grade IV/V (eGFR < 30) (p = 0.548). In elderly patients who underwent TAR, CKD was the independent risk factor of the mortality, but not in the patients who underwent debranching TEVAR. Conversion of surgical strategy from TAR to debranching TEVAR in the treatment of aortic arch aneurysms in the elderly with CKD below Grade IIIa is acceptable considering that less-invasiveness. While, in the elderly with Grade I/II CKD, TAR still remains as a primary choice for the arch repair for better mid-term survival.

Identifiants

pubmed: 33237445
doi: 10.1007/s11748-020-01550-9
pii: 10.1007/s11748-020-01550-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1050-1059

Références

Czerny M, Schmidli J, Adler S, van den Berg JC, Bertoglio L, Carrel T, et al. Editor’s choice—current options and recommendations for the treatment of thoracic aortic pathologies involving the aortic arch: an expert consensus document of the European association for cardio-thoracic surgery (EACTS) & the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2019;57:165–98.
doi: 10.1016/j.ejvs.2018.09.016
Coady MA, Ikonomidis JS, Cheung AT, Matsumoto AH, Dake MD, Chaikof EL, American Heart Association Council on Cardiovascular Surgery and Anesthesia and Council on Peripheral Vascular Disease, et al. Surgical management of descending thoracic aortic disease: open and endovascular approaches: a scientific statement from the American Heart Association. Circulation. 2010;121:2780–804.
doi: 10.1161/CIR.0b013e3181e4d033
Kwon H, Han Y, Noh M, Gwon JG, Cho YP, Kwon TW. Impact of Shaggy aorta in patients with abdominal aortic aneurysm following open or endovascular aneurysm repair. Eur J Vasc Endovasc Surg. 2016;52:613–9.
doi: 10.1016/j.ejvs.2016.08.010
Minatoya K, Ogino H, Matsuda H, Sasaki H, Tanaka H, Kobayashi J, et al. Evolving selective cerebral perfusion for aortic arch replacement: high flow rate with moderate hypothermic circulatory arrest. Ann Thorac Surg. 2008;86:1827–32.
doi: 10.1016/j.athoracsur.2008.07.024
Ogino H, Ando M, Sasaki H, Minatoya K. Total arch replacement using a stepwise distal anastomosis for arch aneurysms with distal extension. Eur J CardiothoracSurg. 2006;29:255–7.
doi: 10.1016/j.ejcts.2005.10.040
Wang T, Shu C, Li M, Li QM, Li X, Qiu J, et al. Thoracic endovascular aortic repair with single/double chimney technique for aortic arch pathologies. J Endovasc Ther. 2017;24:383–93.
doi: 10.1177/1526602817698702
Kato M, Kagaya H, Kubo Y, Banno H, Ohkubo N. Real chimney technique for total debranching of supra-aortic trunks. J Vasc Surg. 2015;61:542–5.
doi: 10.1016/j.jvs.2014.08.066
Stevens PE, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158:825–30.
doi: 10.7326/0003-4819-158-11-201306040-00007
Oda T, Minatoya K, Sasaki H, Tanaka H, Seike Y, Itonaga T, et al. Is conventional open repair still a good option for aortic arch aneurysm in patients of advanced age? Ann Thorac Surg. 2016;101:80–6.
doi: 10.1016/j.athoracsur.2015.06.064
Ikeno Y, Yokawa K, Matsueda T, Yamanaka K, Inoue T, Tanaka H, et al. Long-term outcomes of total arch replacement using a 4-branched graft. J Thorac Cardiovasc Surg. 2019;157:75–85.
doi: 10.1016/j.jtcvs.2018.09.118
Leone A, Beckmann E, Aandreas M, Di Marco L, Pantaleo A, Reggiani LB, et al. Total aortic arch replacement with frozen elephant trunk technique: results from two European institutes. J Thorac Cardiovasc Surg. 2020;159:1201–11.
doi: 10.1016/j.jtcvs.2019.03.121
Yamanaka K, Komiya T, Tsuneyoshi H, Shimamoto T. Outcomes of concomitant total aortic arch replacement with coronary artery bypass grafting. Ann Thorac Cardiovasc Surg. 2016;22:251–7.
doi: 10.5761/atcs.oa.16-00056
Shiraya S, Nakamura Y, Harada S, Kishimoto Y, Onohara T, Otsuki Y, et al. Debranching thoracic endovascular aortic repair for distal aortic arch aneurysm in elderly patients aged over 75 years old. J Cardiothorac Surg. 2020;15:13.
doi: 10.1186/s13019-020-1047-z
Xydas S, Mihos CG, Williams RF, LaPietra A, Mawad M, Wittels SH, et al. Hybrid repair of aortic arch aneurysms: a comprehensive review. J Thorac Dis. 2017;9:S629–34.
doi: 10.21037/jtd.2017.06.47
Shiiya N. Aortic arch replacement for degenerative aneurysms: advances during the last decade. Gen Thorac Cardiovasc Surg. 2013;61:191–6.
doi: 10.1007/s11748-012-0166-4
Okada K, Omura A, Kano H, Nakai H, Miyahara S, Minami H, et al. Outcome of elective total aortic arch replacement in patients with non-dialysis-dependent renal insufficiency stratified by estimated glomerular filtration rate. J Thorac Cardiovasc Surg. 2014;147:966–72.
doi: 10.1016/j.jtcvs.2013.02.046
Kunihara T, Aicher D, Asano M, Takahashi H, Heimann D, Sata F, et al. Risk factors for prophylactic proximal aortic replacement in the current era. Clin Res Cardiol. 2014;103:431–40.
doi: 10.1007/s00392-014-0668-4
Nakamura T, Mikamo A, Matsuno Y, Fujita A, Kurazumi H, Suzuki R, et al. Impact of acute kidney injury on prognosis of chronic kidney disease after aortic arch surgery. Interact Cardiovasc Thorac Surg. 2020;30:273–9.
pubmed: 31642907
Grams ME, Chow EK, Segev DL, Coresh J. Lifetime incidence of CKD stages 3–5 in the United States. Am J Kidney Dis. 2013;62:245–52.
doi: 10.1053/j.ajkd.2013.03.009
Inker LA, Tighiouart H, Aspelund T, Gudnason V, Harris T, Indridason OS, et al. Lifetime risk of stage 3–5 CKD in a community-based sample in Iceland. Clin J Am Soc Nephrol. 2015;10:1575–84.
doi: 10.2215/CJN.00180115

Auteurs

Yoshimasa Seike (Y)

Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, 6-1 Kishibe Shinmachi, Suita, Osaka, 564-8565, Japan.

Koki Yokawa (K)

Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, 6-1 Kishibe Shinmachi, Suita, Osaka, 564-8565, Japan.

Yosuke Inoue (Y)

Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, 6-1 Kishibe Shinmachi, Suita, Osaka, 564-8565, Japan.

Takayuki Shijo (T)

Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, 6-1 Kishibe Shinmachi, Suita, Osaka, 564-8565, Japan.

Kyokun Uehara (K)

Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, 6-1 Kishibe Shinmachi, Suita, Osaka, 564-8565, Japan.

Hiroaki Sasaki (H)

Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, 6-1 Kishibe Shinmachi, Suita, Osaka, 564-8565, Japan.

Tetsuya Fukuda (T)

Department of Radiology, National Cerebral and Cardiovascular Center, Osaka, Japan.

Hitoshi Matsuda (H)

Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, 6-1 Kishibe Shinmachi, Suita, Osaka, 564-8565, Japan. hitmat@mist.ocn.ne.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH